17 results
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
framework in relation to the risks faced by us. Our Board of Directors encourages management to promote a culture that incorporates risk management
6-K
EX-99.1
ddb3scihqi7 75f
6 Jan 22
Report of Foreign Private Issuer
4:02pm
424B4
nps4a7 wj9
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
enkx99rv
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
tdu782nys91ao4
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
6h138p2w
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
99nmgml
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
6-K
EX-99.1
g079x2mz
31 Jul 19
Therapix Biosciences Announces Canadian Product License Issuance for TheraPEA (CannAmide™), a Non-Opiate Based Pain Management Supplement
4:03pm
6-K
EX-99.1
6ym 7n04bsa
23 Jul 19
Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a
4:05pm
20-F
bmu3k3a
1 May 17
Annual report (foreign)
12:00am
- Prev
- 1
- Next